#253 COVID-19 Vaccines with Dr Monica Gandhi
Jan 27, 2021, 08:00 AM
Answer all your burning questions (and your patients’ burning questions) about the different COVID-19 vaccines currently authorized in the US. Infectious diseases / HIV expert, Dr Monica Gandhi @MonicaGandhi9 (UCSF) joins us to cover: the Pfizer-BioNTech and Moderna novel mRNA vaccine mechanisms, trial data, and practicalities of who should receive them. We discuss data around the Oxford-AstraZeneca adenovirus vaccine, which is authorized in the UK and India, and may be available in the US later this year. Feel confident recommending COVID-19 vaccines to your patients!
Episodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com | Free CME!
Credits
- Written and Produced by: Molly Heublein, MD
- Cover Art: Chris Chiu, MD, FACP, FAAP
- Infographic: Tima Karginov
- Hosts: Chris Chiu, MD, FACP, FAAP; Molly Heublein, MD; Paul Williams, MD, FACP
- Editor: Emi Okamoto MD (written materials); Clair Morgan of Nodderly.com (audio)
- Guest: Monica Gandhi, MD, MPH
Sponsor: Panacea Financial
This episode is supported by Panacea Financial, digital banking built for doctors, by doctors. At Panacea Financial you can have your own free personal banker and a support team that works around the clock- just like you do. Open your free checking account today at panaceafinancial.com
Panacea Financial, a Division of Sonabank, Member FDIC
Sponsor: VCU Health CE
The Curbsiders are partnering with VCU Health Continuing Education to offer FREE continuing education credits for physicians and other healthcare professionals. Visit curbsiders.vcuhealth.org.
Time Stamps
- Intro, disclaimer, guest bio - 00:00
- Guest one-liner, book recommendation - 3:40
- Authorized vaccines in the US - 8:30
- AstraZeneca vaccine mechanism- 9:26
- mRNA vaccine mechanism - 10:30
- Vaccine distribution issues (cold chain) - 16:05
- mRNA safety - 18:24
- mRNA vaccine efficacy/data from phase 3 trials - 19:40
- How did we get this so quickly - 23:40
- Vaccine impact on asymptomatic infection - 26:18
- AstraZeneca trials - 28:20
- Pregnancy - 35:10
- Anaphylaxis - 37:10
- Prior COVID-19 infection - 39:07
- Side effects - 42:05
- Pediatric patients - 45:12
- Phases of role outs in the US -46:50
- Herd immunity - 48:16
- Thoughts of how to make this happen - 52:45
- Preexisting conditions - 53:40
- How long will immunity last - 57:15
- Mutant strains - 58:25
- Future of mRNA vaccines - 1:00:30
- Take home points and Outro - 1:02:12